Priveterra Acquisition Corp.
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $276.00M |
|---|---|
| IPO Date | Feb 9, 2021 |
| CEO | Robert Palmisano |
| Left Lead | Wells Fargo |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 6 |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | AEON Biopharma |
| Deal Announced | Dec 13, 2022 |
| Deal Size, $M | $248.10M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jul 3, 2023 |
| Amendment Vote | Feb 10, 2023 |
| Closing Date | Jul 21, 2023 |
Formerly PMGM
AEON
AEON/W
| Price | $0.72 $0.01 |
|---|---|
| Last closing price | $0.75 |
| H/L, today | $0.65 / $0.75 |
| H/L, 52-week | $3.37 / $11.88 |
| Volume, today | 227,905 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.